The role of novel chitin-like polysaccharides in Alzheimer disease

Neurotoxicity Research

Volumn 12, Issue 4, 2007, Pages 269-274

  Castellani, Rudy J ^a   Perry, George ^b,c   Smith, Mark A ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c University of San Antonio   (United States)

Author keywords

Alzheimer disease; Amyloid ; Amyloidoses; Calcofluor; Chitin; Glucosamine; Plaques

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; AMYLOSE; CHITIN; GLUCOSAMINE; GLUCOSE; GLUCOSE POLYMER; HEXOSAMINE; POLYSACCHARIDE; HEPARAN SULFATE;

ALZHEIMER DISEASE; AMINO ACID ANALYSIS; ARTICLE; CARBOHYDRATE SYNTHESIS; GLUCOSE UTILIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; MATRIX ATTACHMENT REGION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; AMYLOIDOSIS; ANIMAL; BRAIN LEVEL; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANIMALS; BRAIN CHEMISTRY; CHITIN; HEPARITIN SULFATE; HUMANS; POLYSACCHARIDES; SENILE PLAQUES;

EID: 41749110081     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033910     Document Type: Article

References (42)

1. Bakkers J, CE Semino, H Stroband, JW Kijne, PW Robbins and HP Spaink (1997) An important developmental role for oligosaccharides during early embryogenesis of cyprinid fish. Proc. Natl. Acad. Sci. USA 94, 7982-7986.
2. (1-40) prevents heparinase-catalyzed degradation of heparin sulfate glycosaminoglycans and proteoglycans in vitro. J. Biol. Chem. 272, 17005-17011.
3. Berenson GS, ER Dalferes, H Ruitz and B Radhakrishmamurthy (1969) Changes of acid mucopolysaccharides in the heart involved by amyloidosis. Am. J. Cardiol. 24, 358-364.
4. Bitter T and H Muir (1965) Mucopolysaccharides in amyloidosis. Lancet 1, 819.
5. Brownlee M (2000) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
6. Castellani RJ, AE Fortino, R Common, G Perry, B Ghetti and MA Smith (2004) Calcofluor statins amyloid-beta deposits. J. Neuropathol Exp. Neurol. 63, 524.
7. Castellani RJ, SL Siedlak, AE Fortino, G Perry, B Ghetti and MA Smith (2005) Chitin-like polysacchandes in Alzheimer's disease brains. Curr. Alzheimer Res. 2, 419-423
8. Castillo GM, W Lukito, TN Wight and AD Snow (1999) The sulfate moieties of glycosaminoglycans are critical for the enhancement of β-amyloid protein fibril formation. J. Neurochem. 72, 1681-1687.
9. Clausen J and HE Christensen (1964) Paraproteins and acid mucopolysaccharides in primary amyloidosis. Acta Pathol Microbiol. Scand. 60, 493-510.
10. Cotran RS, V Kumar, T Collins and SL Robbins (Eds.) (1999) Robbins Pathologic Basis of Disease, 6th Edition (WB Saunders, Philadelphia, PA, USA), pp 1425.
11. Dalferes ER, B Radhakrislunamurthy and GS Berenson (1967) Acid mucopolysaccharides in amyloid tissues. Acta Biochem. Biophys. 118, 284-291.
12. DeWitt DA, J Silver, DR Canning and G Perry (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 121, 149-152.
13. Fraser PE, JT Nguyen, DT Chin and DA Kirschner (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions. J. Neurochem. 59, 1531-1540.
14. Friedreich N and A Kekule (1859) Zur amyloidfrage. Virch Arch. Path. Anat. Physiol. 16, 50-65.
15. Garcia-Zapien AG, A Gonzales-Robles and J Mora-Galindo (1999) Congo red effect on cyst viability and cell wall structure of encysting. Entamoeba invadens. Arch. Med. Res. 30, 106-115.
16. Glaser L and DH Brown (1957) The synthesis of chitin in cellfiee extracts of Neurospora Crassa. J. Biol. Chem. 228, 729-742.
17. Houston DR, AD Recklies, JC Krupa and DMF van Aalten (2003) Structure and ligand-induced conformational change of the 39-kDa glycoprotein from human articular chondrocytes. J Biol. Chem. 278, 30206-30212.
18. Huang L, RI Hollingsworth, R Castellani and B Zipser (2004) Accumulation of high-molecular-weight amylose in Alzheimer's disease brains. Glycobiology 14, 409-416.
19. Ishii K, M Sasaki, H Kitagaki, S Yamaji, S Sakamoto, K Matsuda and E Mori (1997) Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J. Nucl. Med. 38, 925-928.
20. Joseph J, B Shukitt-Hale, NA Denisova, A Martin, G Perry and MA Smith (2001) Copernicus revisited anyloid beta in Alzheimer's disease. Neurobiol. Aging. 22, 131-146.
21. Klis FM, P Mol, K Hellingwerf and S Brul (2002) Dynamics of cell wall structure in Saccharomyces cerevisiae. FEMS Microbiol Rev. 26, 239-259.
22. Ling H and AD Recklies (2004) The chitinase 3-like protein HC-gp39 inhibits cellular responses to the inflammatory cytokines interleukin 1 and tumor necrosis factor-α. Biochem. J. 380, 651-659.
23. Meyer MF and G Kreil (1996) Cells expressing the DG42 gene from early Xenopus embryos synthesize hyaluronan. Proc. Natl. Acad. Sci. USA 93, 4543-4547.
24. Niwa K, K Kazama, SG Younkin, GA Carlson and C Iadecola (2002) Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein Neurobiol. Dis. 9, 61-68.
25. Pennock CA (1968) Association of acid mucopolysaccharides with isolated amyloid fibrils. Nature 21, 753-754
26. Pennock CA, J Bruns and G Massarella (1968) Histochemical investigation of acid mucosubstances in secondary amyloidosis. J. Clin. Pathol. 21, 578-581.
27. Recklies AD, C White and H Ling (2002) The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem. J. 365, (Pt. 1), 119-126.
28. Rottkamp CA, AK Raina, X Zhu, E Gaier, AI Bush, CS Atwood, M Chevion, G Perry and MA Smith (2001) Redoxactive iron mediates amyloid-beta toxicity. Free Radic. Biol. Med. 30, 447-450.
29. Semino CE, CA Specht, A Raimondi and PW Robbins (1996) Homologs of the Xenopus developmental gene DG42 are present in zebrafish and mouse and are involved in the synthesis of Nod-like chitin oligosaccharides during early embryogenesis. Proc. Natl. Acad. Sci. USA 93, 4548-4553.
30. Simpson IA, KR Chundu, T Davies-Hill, WG Honer and P Davies (1994) Decreased concentrations of GLUTI and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35, 546-551.
31. Smith MA, G Casadesus, JA Joseph and G Perry (2002) Amyloid-sb and τ serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol. Med. 33, 1194-1199.
32. Snow AD and R Kisilevsky (1985) Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis A histochemical study. Lab. Invest. 53, 37-44.
33. Snow AD, J Willmer and R Kisilevsky (1987) A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils. Lab. Invest. 57, 687-698.
34. Snow AD, H Mar, D Nochlin, K Kimata, M Sate, S Suzuki, J Hassell and TN Wight (1988) The presence of hepaian sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
35. Snow AD, R Sekiguchi, D Nochlin, P Fraser, K Kimata, A Mizutani, M Arai, WA Schreier and DG Morgan (1994) An important role of heparan sulfate proteoglycan (Perlecan in a model system for the deposition and persistence of fibrillan Abeta-unyloid in rat brain. Neuron 12, 219-234.
36. Szumanska G, AW Vorbrodt, TI Mandybur and HM Wisniewski (1987) Lectin histochemistry of plaques and tangles in Alzheimer's disease. Acta Neuropathol. 73, 1-11.
37. Tanwar MK, MR Gilbert and EC Holland (2002) Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res 62, 4361-4368.
38. Ueno H, F Nakamura, M Murakami, M Okunura, T Kadosawa and T Fujinag (2001) Evaluation effects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages Biomaterials 22, 2125-2130
39. Verkkoniemi A, H Kalimo, A Paetau, M Somer, T Iwatsubo, J Hardy and M Haltia (2001) Variant Alzheimer disease with spastic parapariesis neuropathological phenotype. J. Neuropathol. Exp. Neurol. 60, 483-492.
40. Virchow R (1854) On a new substance found in the human brain and spinal cord which reacts chemically like cellulose Virch. Arch. Path. Anat. Physiol. 6, 135-137
41. Wyss-Coray T and L Mucke (2002) Inflammation in neurodegenerative disease - a double-edged sword. Neuron 35, 419-432.
42. Yoshida M, N Itano, Y Yamada and K Kimata (2002) In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amano acid residues essential for the activity. J. Biol. Chem. 275, 497-506.